[The relevant factors and strategies related efficacy with standard of care  in chronic hepatitis C treatment naive patients].
Xiao-guang
XG
Dou
D000998:Antiviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004279:DNA, Viral / Q000097:blood; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000627:therapeutic use; D012254:Ribavirin / Q000008:administration & dosage* / Q000627:therapeutic use; D059039:Standard of Care
D000998:Antiviral Agents; D004279:DNA, Viral; D016898:Interferon-alpha; D012254:Ribavirin